Fresolimumab
From Self-sufficiency
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Template:Infobox drug/mab source |
| Target | TGF beta 1, 2 and 3 |
| Identifiers | |
| CAS Number | 948564-73-6 |
| ATC code | none |
| Chemical data | |
| Formula | C6392H9926N1698O2026S44 |
| Molar mass | 144.4 kDa[[Script error: No such module "String".]] |
Fresolimumab is a human monoclonal antibody[1] and an immunomodulator, developed by Genzyme. It is intended for the treatment of idiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, and cancer,[2][3] but has not entered clinical trials as of October 2009[update].[4]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Articles containing potentially dated statements from October 2009
- Articles with invalid date parameter in template
- All articles containing potentially dated statements
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs
